In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Call for Innovation in AI and digital medicine in clinical EP

EHRA 2026, Paris & Online from 12 to 14 April

The Call for Innovation in AI and digital medicine in clinical EP is for clinicians, scientists and engineers. The invention or innovation should be on the broad topic of cardiac arrhythmias and tackle a novel approach.
It could be a developed software, a new device, a new use for a drug or other small molecule, or bringing a business approach to an aspect of cardiac rhythm management that can be considered an invention. All pre-commercial revenue stages will be considered, so the idea may be still in basic research, or have progressed all the way to early clinical trials, but it should have moved beyond the idea stage.

Criteria of eligibility:

    • Has an innovation with relevance to the first of clinical EP or works in clinical EP
    • Has developed an invention

Give your work the visibility it deserves

Present your developed software, new device, new use for a drug or other small molecule, or a business approach to an aspect of cardiac rhythm management that can be considered as an invention. Engage with fellow researchers, key opinion leaders, potential co-investigators and mentors in your field.

Give your work the visibility it deserves

The call for Innovation in AI and digital medicine in clinical EP is now open.

Submission deadline is Tuesday 13 January 2026, 12:00 noon CET.

Don't wait until the last minute.

Submit now

Key dates

  • Thursday, 6 November 2025 - Opening submissions
  • Tuesday, 13 January 2026, 12:00 noon CET - Submission deadline
  • Mid-February 2026 - Results announcement. An email will also be sent to each submitter.

Preparing your submission

Format of the session

All presenters will be required to present their research onsite in Paris.

The highest graded submissions will be selected to be presented orally during a dedicated session which will be held onsite moderated by senior faculty members.

All finalists will be granted a free congress registration for EHRA 2026.
The winner will get an additional free registration for EHRA 2027.

About the ESC
Press and Media
Information
Follow us

         

 Need help?

 Help centre
 Contact us

© 2025 European Society of Cardiology. All rights reserved.